«Retailers can now add a therapeutic benefit to their existing pet bed inventory and
continue the therapy benefit to all the carriers and strollers they sell,» adds Silber.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or
continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs);
continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell
therapies utilizing the zinc finger nuclease technology platform and realize the
benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other
therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Researchers in US and Canada funded by the Cooperative Studies Program of the Department of Veterans Affairs and the Canadian Institutes for Health Research compared the costs and
benefits of etanercept - methotrexate first versus triple
therapy first in 353 patients enrolled in the RACAT trial who
continued to have uncontrolled symptoms of RA after at least 12 weeks of methotrexate
therapy.
Patients with metastatic colorectal cancer (mCRC) that are mutation - free in the KRAS, NRAS, BRAF and PIK3CA genes showed significant
benefit from
continuing anti-epidermal growth factor receptor (EGFR)
therapy beyond progression following first - line chemotherapy and an anti-EGFR monoclonal antibody, according to study results (1) presented today at the ESMO 17th World Congress on Gastrointestinal Cancer in Barcelona, Spain.
Previous studies have shown a
benefit in adding a second antiplatelet drug like ticagrelor, from a class called P2Y12 inhibitors, but they investigated the additional
therapy for only a year, leaving unanswered the question of whether patients would
benefit from
continuing this treatment longer.
Previous randomised trials comparing the efficacy of insulin pump
therapy and multiple injections in people with type 2 diabetes have not provided consistent evidence, and the
benefits of pump
therapy continue to be debated.
In addition, McTiernan and colleagues suggest that health - care providers may want to track breast - density change during regular mammography screenings and use this information as part of the risk -
benefit assessment when helping women choose whether to
continue hormone
therapy.
«So if you're not using it, there's no reason to expect the
continued benefit for a treatment that works that way, whereas cognitive behavioral
therapy teaches skills.»
In the next year, members of the Dream Team will
continue to study the tumor microenvironment before and after checkpoint blockade, to develop algorithms to identify and predict the best antigens on cancer cells that can be used for cancer immunotherapies, to analyze tumor tissues and blood for biomarkers that will help in selecting patients who will
benefit, and identifying the best approaches to increase the strength of immune cells for adoptive cell
therapy.
«We found that the moderate
benefit that psychological
therapies confer in the short term
continue over the long term.
Although it is often suggested that children with epilepsy who are
benefiting from ketogenic dietary
therapy continue this for at least two years, duration of treatment could be shorter in patients with infantile spasms who become seizure - free; one study reported no adverse effect on seizure outcomes and less risk of growth disturbances when treatment was tapered down after 8 months (15).
Music
therapy continues to show numerous health
benefits for people with conditions ranging from mild stress to severe, like say cancer.
While traditional talk
therapy offers
benefits when managing mood issues, sometimes clients are left with a
continued state of unease with life.
Seeing the
continued dedication of health professionals in the field of dietary
therapy gives Tammy hope that all children in need may
continue to
benefit from their hard work.
The new evidence shouldn't be seen as an endorsement of hormone
therapy, as the risks associated with the drugs
continue to outweigh the
benefits for many women.
She is motivated to
continue her research in nutritional
therapies for many reasons, most significantly for the
benefits it has brought to her sons with specific learning needs.
As animal lovers, it is important we
continue to follow the latest studies in animal
therapies so we can inform people who might
benefit from the information, but as Soulpaws shows us, it is equally important to make sure that the animals who help their humans on a daily basis are also being looked out for as well.
Canine Assisted
Therapy's vision is to be recognized as the premier pet therapy organization by developing and utilizing the highest standards possible, educating the public about the benefits of animal assisted therapy and animal assisted activities, and providing continued support to its volunteers and faci
Therapy's vision is to be recognized as the premier pet
therapy organization by developing and utilizing the highest standards possible, educating the public about the benefits of animal assisted therapy and animal assisted activities, and providing continued support to its volunteers and faci
therapy organization by developing and utilizing the highest standards possible, educating the public about the
benefits of animal assisted
therapy and animal assisted activities, and providing continued support to its volunteers and faci
therapy and animal assisted activities, and providing
continued support to its volunteers and facilities.
C.A.T.'s vision is to be recognized as the premier pet
therapy organization by developing and utilizing the highest standards possible, educating the public about the
benefits of animal assisted
therapy and animal assisted activities, and providing
continued support to its volunteers and facilities.
Comprehensive consultations, assessments and analysis combined with specifically designed
therapies will ensure that your detox is conducted in a professional and healthy environment, whilst a month's supplements will ensure that the
benefits of your detox
continue when you return home.
OpenUrlCrossRefPubMedWeb of Science Q Does the addition of behaviour
therapy to
continuing medication
benefit people with obsessive - compulsive disorder who have responded to drug treatment?
Research on psychodynamic
therapy shows that not only is it effective in helping people resolve their problems, it even
continues to increase its
benefits after treatment ends.
Benefits and Risks —
Therapy is an open and dynamic process; its course is dependent upon our mutual willingness to collaboratively
continue the process, as well as upon unforeseeable life events.
However generally by your third visit you and your therapist should have a common understanding of how
therapy may be of
continued benefit to you.
Through your support, AFTNC can
continue to promote family
therapy in Northern California, membership includes many personal and professional
benefits.
The American Association for Marriage and Family
Therapy requires members to adhere to a «Code of Ethics», including a commitment to «
continue therapeutic relationships only so long as it is reasonably clear that clients are
benefiting from the relationship.»